Efectos de la erradicación de Helicobacter pylori sobre el reflujo gastroesofágico patológico en pacientes con úlcera duodenal
Background: Helicobacter pylori infection is not a risk factor for gastroesophageal reflux disease and it could even be a protector factor. Aim: To study the relationship between H pylori eradication and gastroesophageal reflux symptoms in patients with duodenal ulcer. Patients and methods: One hund...
Guardado en:
Autores principales: | , , |
---|---|
Lenguaje: | Spanish / Castilian |
Publicado: |
Sociedad Médica de Santiago
2002
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872002000200004 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:scielo:S0034-98872002000200004 |
---|---|
record_format |
dspace |
spelling |
oai:scielo:S0034-988720020002000042014-08-20Efectos de la erradicación de Helicobacter pylori sobre el reflujo gastroesofágico patológico en pacientes con úlcera duodenalRollán R,AntonioGiancaspero P,RossanaFuster S,Francisco Duodenal ulcer Gastroesophageal reflux Helicobacter pylori Background: Helicobacter pylori infection is not a risk factor for gastroesophageal reflux disease and it could even be a protector factor. Aim: To study the relationship between H pylori eradication and gastroesophageal reflux symptoms in patients with duodenal ulcer. Patients and methods: One hundred eleven patients with duodenal ulcer and treated for H pylori infection were studied. In 96 patients, H pylori was successfully eradicated and were evaluated every four months with endoscopy, during the first year. Thereafter, an annual clinical assessment was performed and endoscopy was repeated only if clinically indicated. Results: Patient were followed for a mean of 41 months (range 4 months to 6 years). Twelve patients (10.8%) had esophagitis at recruitment and in nine, H pylori was eradicated. The frecuency of gastroesophageal reflux symptoms or esophagitis in this group was similar to the rest of patients. During the first year, the frecuency of reflux symptoms ranged from 9 to 19%. The frecuency of esophagitis persisted at about 10%, although 81% of patients with esophagitis did not have it on recruitment. After the first year, the frecuency of reflux symptoms declined significantly to about 8%. Conclusions: In these patients with duodenal ulcer, gastroesophageal reflux disease had a variable evolution after H pylori eradication (Rev Méd Chile 2002; 130: 153-9)info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.130 n.2 20022002-02-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872002000200004es10.4067/S0034-98872002000200004 |
institution |
Scielo Chile |
collection |
Scielo Chile |
language |
Spanish / Castilian |
topic |
Duodenal ulcer Gastroesophageal reflux Helicobacter pylori |
spellingShingle |
Duodenal ulcer Gastroesophageal reflux Helicobacter pylori Rollán R,Antonio Giancaspero P,Rossana Fuster S,Francisco Efectos de la erradicación de Helicobacter pylori sobre el reflujo gastroesofágico patológico en pacientes con úlcera duodenal |
description |
Background: Helicobacter pylori infection is not a risk factor for gastroesophageal reflux disease and it could even be a protector factor. Aim: To study the relationship between H pylori eradication and gastroesophageal reflux symptoms in patients with duodenal ulcer. Patients and methods: One hundred eleven patients with duodenal ulcer and treated for H pylori infection were studied. In 96 patients, H pylori was successfully eradicated and were evaluated every four months with endoscopy, during the first year. Thereafter, an annual clinical assessment was performed and endoscopy was repeated only if clinically indicated. Results: Patient were followed for a mean of 41 months (range 4 months to 6 years). Twelve patients (10.8%) had esophagitis at recruitment and in nine, H pylori was eradicated. The frecuency of gastroesophageal reflux symptoms or esophagitis in this group was similar to the rest of patients. During the first year, the frecuency of reflux symptoms ranged from 9 to 19%. The frecuency of esophagitis persisted at about 10%, although 81% of patients with esophagitis did not have it on recruitment. After the first year, the frecuency of reflux symptoms declined significantly to about 8%. Conclusions: In these patients with duodenal ulcer, gastroesophageal reflux disease had a variable evolution after H pylori eradication (Rev Méd Chile 2002; 130: 153-9) |
author |
Rollán R,Antonio Giancaspero P,Rossana Fuster S,Francisco |
author_facet |
Rollán R,Antonio Giancaspero P,Rossana Fuster S,Francisco |
author_sort |
Rollán R,Antonio |
title |
Efectos de la erradicación de Helicobacter pylori sobre el reflujo gastroesofágico patológico en pacientes con úlcera duodenal |
title_short |
Efectos de la erradicación de Helicobacter pylori sobre el reflujo gastroesofágico patológico en pacientes con úlcera duodenal |
title_full |
Efectos de la erradicación de Helicobacter pylori sobre el reflujo gastroesofágico patológico en pacientes con úlcera duodenal |
title_fullStr |
Efectos de la erradicación de Helicobacter pylori sobre el reflujo gastroesofágico patológico en pacientes con úlcera duodenal |
title_full_unstemmed |
Efectos de la erradicación de Helicobacter pylori sobre el reflujo gastroesofágico patológico en pacientes con úlcera duodenal |
title_sort |
efectos de la erradicación de helicobacter pylori sobre el reflujo gastroesofágico patológico en pacientes con úlcera duodenal |
publisher |
Sociedad Médica de Santiago |
publishDate |
2002 |
url |
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872002000200004 |
work_keys_str_mv |
AT rollanrantonio efectosdelaerradicaciondehelicobacterpylorisobreelreflujogastroesofagicopatologicoenpacientesconulceraduodenal AT giancasperoprossana efectosdelaerradicaciondehelicobacterpylorisobreelreflujogastroesofagicopatologicoenpacientesconulceraduodenal AT fustersfrancisco efectosdelaerradicaciondehelicobacterpylorisobreelreflujogastroesofagicopatologicoenpacientesconulceraduodenal |
_version_ |
1718436013440761856 |